Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
Search for Tasly-performance Sorting by the latest release time

  • Tasly in cooperation with Arbor on T89 R&D and marketing

    Tasly Pharmaceutical Group Co., Ltd. (referred to as “Tasly”) and the US-based drug maker Arbor Pharmaceuticals, Inc. (referred to as “Arbor”) announced on Sep. 6 comprehensive cooperation in the R&D and marketing of T89 in the States. 

    September09,2018


  • Tasly invests in Mesoblast, introduces two stem cell products

    Tasly Pharmaceutical Group CO.,LTD (600535.SH) announced that it had inked investment agreement and product development commercialization agreement with Mesoblast, the world's leading stem cell R&D company.

    July18,2018


  • Ask Us A Question belt & road login close

    If you have any questions, please enter them in the box below.

    Identifying code Reload

    Write to Us belt & road login close

    Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

    Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

    Start a Free Trial